NEW YORK, Jan. 28-Inpharmatica and Serono are expanding their proteomics collaboration, the two companies said this morning.
The two firms struck a collaboration in mid-2001 in which Inpharmatica supplies Serono with protein sequences to aid in drug and drug target discovery.
This agreement expands the deal, so that Inpharmatica will provide additional proprietary genomic sequence data from other protein families.
Inpharmatica will receive milestone and royalty payments based on any products developed, as well as additional research funding.
Inpharmatica, based in London, uses informatics and a large compute farm to analyze protein data for drug discovery.